CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · General Reference

Griseofulvin

antifungal medication used for dermatophytoses

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionFeb 12, 2026
Entity authorityQ416096 ↗
Source-derived summary

Griseofulvin is an antifungal medication used to treat dermatophytoses (ringworm). This includes fungal infections of the nails and scalp, as well as the skin when antifungal creams have not worked. It is taken by mouth.

Common side effects include allergic reactions, nausea, diarrhea, headache, trouble sleeping, and feeling tired. It is not recommended in people with liver failure or porphyria. Use during or in the months before pregnancy may result in harm to the baby. Griseofulvin works by interfering with fungal mitosis.

Griseofulvin was discovered in 1939 from the soil fungus Penicillium griseofulvum. It is on the World Health Organization's List of Essential Medicines.

Medical uses

Griseofulvin is used orally only for dermatophytosis.

Editorial summary

The public source identifies “Griseofulvin” as antifungal medication used for dermatophytoses. This brief keeps that definition visible, then builds a research path around Griseofulvin, antifungal and medication.

Editorial reviewA practical starting point whose main value is the path it opens into stronger specialist and primary sources. The current lead gives the account dated anchors—1939—that can be checked directly. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with Griseofulvin, antifungal and medication providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “Griseofulvin”, the useful work is to connect “antifungal medication used for dermatophytoses” to the records capable of establishing context and consequence.

Evidence profile

Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Feb 12, 2026. The linked authority identifier is Q416096. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1939.

Critical limits

A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Griseofulvin”, its source revision and the description used here.
  2. Expand the search: follow Griseofulvin primary sources, Griseofulvin archive and Griseofulvin research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Griseofulvin”?
  2. What terminology or title could unlock a more precise catalogue search?
  3. Which institution is responsible for the underlying evidence?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Griseofulvin” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.